Effect of withdrawal of hormone replacement therapy on bone mass and bone turnover: the OFELY study. (Q50724010)

18 March 2018

title

Effect of withdrawal of hormone replacement therapy on bone mass and bone turnover: the OFELY study. (English)

1 reference

18 March 2018

Hormone Replacement Therapy

main subject

1 reference

inferred from title

author name string

Elisabeth Sornay-Rendu

1

1 reference

18 March 2018

Patrick Garnero

2

1 reference

18 March 2018

Françoise Munoz

3

1 reference

18 March 2018

François Duboeuf

4

1 reference

18 March 2018

Pierre D Delmas

5

1 reference

18 March 2018

publication date

1 July 2003

1 reference

18 March 2018

published in

Bone

1 reference

18 March 2018

volume

33

1 reference

18 March 2018

issue

1

1 reference

18 March 2018

page(s)

159-166

1 reference

18 March 2018

Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Course of bone mass during and after hormonal replacement therapy with and without addition of nandrolone decanoate

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Long-term estrogen replacement therapy prevents bone loss and fractures

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

The effect of postmenopausal estrogen therapy on bone density in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Bone mass response to discontinuation of long-term hormone replacement therapy: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Safety Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

A comparison of the effects of oestrogen/progestogen, high-dose oral calcium, intermittent cyclic etidronate and an ADFR regime on calcium kinetics and bone mass in postmenopausal women with spinal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Effect on bone of withdrawal of oestrogen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Therapeutic strategies in the prevention of hip fracture with drugs affecting bone metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

The risk of hip fracture in postmenopausal females with or without estrogen drug exposure

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Prevention of spinal osteoporosis in oophorectomised women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Bone response to termination of oestrogen treatment

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Fracture protection provided by long-term estrogen treatment

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Exercise and other factors in the prevention of hip fracture: the Leisure World study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Menopausal estrogen therapy and hip fractures

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Biochemical markers of bone turnover to monitor the bone response to postmenopausal hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900171-6

7 January 2021

10.1016/S8756-3282(03)00171-6

Identifiers

DOI

1 reference

18 March 2018

PubMed ID

12919711

1 reference

18 March 2018